Georgia's Online Cancer Information Center

Find A Treatment Site

Cancer Center at DeKalb Medical Center

Dekalb Medical Cancer Center is accredited by the Commission on Cancer of the American College of Surgeons as a community hospital comprehensive oncology program and is accredited by the American College of Radiology (ACR). As an affiliate member of Augusta University's Georgia Cares Minority Underserved National Cancer Institute of Community Oncology Research Program (Georgia Cares MU NCORP), a program initiated by the National Cancer Institute (NCI) to provide community hospitals access to a wide range of clinical research studies, Dekalb Medical offers an array of clinical trials. DeKalb Medical is also a member of the Georgia CORE Research Network, a statewide network of academic and community-based oncologists and researchers. The center is also a recipient of the Georgia Cancer Coalition Distinguished Cancer Scholars Award, which supports leaders who are engaged in the most promising areas of cancer research. DeKalb Medical has four units specially designed to provide state-of-the-art clinical care to cancer patients. These include the specialized inpatient oncology unit; outpatient infusion center; radiation oncology center and comprehensive breast care center. They also offer genetic risk assessment services. Through cancer support groups, nutrition program, Return to Wellness program and the Hope and Healing program, Dekalb Medical provides several support systems to cancer patients and their families.

Treatment Sites in Georgia

Clinical Trials in Georgia

Chemotherapy and Pelvic Radiation Therapy with or without Additional Chemotherapy in Treating Patients with High-Risk Early-Stage Cervical Cancer after Radical Hysterectomy
Cancer Type: Cervical Cancer

Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Cancer Type: Lung Cancer

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel with or without Carboplatin in Treating Patients with Triple-Negative Breast Cancer
Cancer Type: Breast Cancer

Genetic Testing in Screening Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Cancer Type: Lung Cancer

Lymph Node Dissection and Radiation Therapy in Treating Patients with Breast Cancer Previously Treated with Chemotherapy and Surgery
Cancer Type: Breast Cancer, Unknown Primary

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Bladder Cancer, Brain & Spinal Cord Tumor, Breast Cancer, Cervical Cancer, Colon/Rectal Cancer, Esophogeal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer / Hepatoblastoma, Lung Cancer, Lymphoma, Melanoma, Multiple Myeloma, Ovarian Cancer, Pancreatic Cancer, Plasma cell neoplasm, Prostate Cancer , Skin Cancer (Non-Melanoma), Stomach/ Gastric Cancer, Thyroid Cancer, Unknown Primary, Uterine Cancer

Use of a Clinical Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)
Cancer Type: Quality of Life
**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please contact us.
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.